Clementia Pharmaceuticals

Healthcare 📍 Montréal, Canada 👥 51-200 employees 💰 $92.5M raised 📅 Founded 2012

Clementia is a biopharmaceutical company dedicated to bringing effective new treatments to people who have none. Clementia is rapidly developing its first lead product candidate, palovarotene, to treat fibrodysplasia ossificans progressiva (FOP), an ultra-rare and severely disabling disorder, and other diseases.

🌐 Website in LinkedIn ← All Companies

📊 Company Overview

Sector

Healthcare

Country

Canada

Employees

51-200

Total Raised · Venture

$92.5M

Founded

2012

Cloud

AWS

Email

Microsoft 365

☁️ Cloud Infrastructure

AWS Detected Cloud Provider

Detected via HTTP headers

Workspace	Microsoft 365
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$450K – $1M / year on AWS

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	🔒 Subscribers only
Frontend Stack	🔒 Subscribers only

Detected from Clementia Pharmaceuticals's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Mylan Specialty

201-500 ☁️ AWS

201-500 ☁️ Cloudflare

Park Hotels & Resorts

51-200 ☁️ Unknown

Data detected 2026-06-13 · Methodology · Suggest a correction